| Patient | Vivekananda |
|---|---|
| Date of birth | 1863-01-12 |
| Identifiers | MRN HR-NI032-SYN-TD; SSN (made up) 000-32-9014 |
| Document date | 1898-02-16 |
| Author | Anjali Thornbury-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Diagnosis visit: fasting test results with the endocrinology consultation. [S]
Swami Vivekananda returns one week after his first visit, fasting since the evening meal, for blood tests drawn this morning and his consultation with Dr. Lindqvist-Bose. He is still thirsty and passes urine three times a night. He has drunk water freely as advised. A few days ago he kept the night-long fast of a major festival, without water until the next morning, and felt light-headed and very thirsty by dawn; he asked how he can keep his fasts safely. His home blood pressure readings over the week averaged 136/86. He wants to know what kind of diabetes this is and whether he will need injections. [S]
| Element | Detail |
|---|---|
| Symptoms | Thirst; nocturia three times; tiredness; weight 72.8 kg |
| Fasting | A night-long waterless festival fast a few days ago, with light-headedness by dawn |
| Home blood pressure | Average 136/86 over seven days |
| His questions | What kind of diabetes, whether injections are needed, and how to keep his fasts |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; weight down a further 0.2 kg |
| Genitourinary | Positive | Frequent urination, three times a night |
| Eyes | Positive | Reading vision blurred at times |
| Gastrointestinal | Negative | No abdominal pain, nausea or vomiting |
| Neurological | Negative | No numbness or tingling |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin extended-release 500 mg tablets: two tablets (1000 mg) with the evening meal, starting with one for the first week | 1000 mg with the evening meal | Oral route | 1898-02-16 to 1898-03-23 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1898-02-16 | Body height | 172 | cm | S |
| 1898-02-16 | Body weight | 72.8 | kg | S |
| 1898-02-16 | Body mass index (BMI) [Ratio] | 24.6 | kg/m2 | S |
| 1898-02-16 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1898-02-16 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 1898-02-16 | Heart rate | 80 | /min | S |
| 1898-02-16 | Respiratory rate | 16 | /min | S |
| 1898-02-16 | Body temperature | 36.7 | Cel | S |
| 1898-02-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1898-02-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 9.4 | % | Below 5.7% is normal; 6.5% or more diabetes; his target below 7% | High | S |
| 1898-02-16 | Glucose [Mass/volume] in Serum or Plasma | 172 | mg/dL | Fasting; 126 mg/dL or more indicates diabetes | High | S |
| 1898-02-16 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay | 1.2 | [IU]/mL | Below 5 IU/mL negative | Normal | S |
| 1898-02-16 | C peptide [Mass/volume] in Serum or Plasma | 2.6 | ng/mL | 0.8-3.5 ng/mL | Normal | S |
| 1898-02-16 | Albumin/Creatinine [Mass Ratio] in Urine | 46 | mg/g | 30 to 299 moderately increased; 300 or more severely increased | High | S |
| 1898-02-16 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 1898-02-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 36 | mg/dL | 40 mg/dL or more for men | Low | S |
| 1898-02-16 | Triglyceride [Mass/volume] in Serum or Plasma | 228 | mg/dL | <=149 mg/dL | High | S |
| 1898-02-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 132 | mg/dL | <=99 mg/dL | High | S |
| 1898-02-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-55 U/L | Normal | S |
| 1898-02-16 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1898-02-16 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 312 | pg/mL | 232-1245 pg/mL | Normal | S |
Vital signs recorded on 1898-02-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, alert and forthright; weight 72.8 kg, BMI 24.6; blood pressure 136/86, pulse 80 |
| Skin | No acanthosis nigricans; mucous membranes moist |
| Feet | Skin intact; pulses present; monofilament and vibration sense normal |
| Cardiovascular | Regular rhythm; no edema |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Thirst, frequent urination day and night, tiredness and about 4 kg weight loss over two months, with a random glucose of 246 mg/dL; told by physicians a year ago that he had diabetes, never confirmed with modern tests or treated except by diet. Diabetes to be confirmed and classified (type 2, type 1 or slowly progressive autoimmune diabetes) with A1c, fasting glucose, GAD antibodies and C-peptide | resolved | confirmed | R73.9 | S — Synthetic presenting problem anchored to his documented diabetes of the year before. Superseded by the diagnosis at the second visit. |
| Type 2 diabetes: A1c 9.4 percent and fasting glucose 172 mg/dL, with symptoms; GAD65 antibodies negative and fasting C-peptide preserved (2.6 ng/mL); no ketones. BMI 24.6, in the range where ADA screens Asian Americans. Classified as type 2, not type 1 or slowly progressive autoimmune diabetes | active | confirmed | E11.65 | S — Synthetic modern confirmation and classification linked to his documented diabetes. |
| Moderately increased albuminuria on a first sample (urine albumin-to-creatinine ratio 46 mg/g), eGFR normal; to be confirmed on two of three samples over three to six months | active | confirmed | R80.9 | S — Synthetic finding linked to his documented albuminuria; superseded when diabetic kidney disease was confirmed. |
| Raised blood pressure in clinic (138/86, average of two readings) without a diagnosis of hypertension; home readings to be taken | active | confirmed | R03.0 | S — Synthetic finding; not a claim about his real blood pressure. |
| Long-standing difficulty falling asleep: by his own account he has never been able to fall asleep on getting into bed and lies awake for two hours or more most nights; worse lately with waking to pass urine; rises before dawn for meditation | active | confirmed | G47.00 | S — Synthetic modern problem linked to his documented lifelong difficulty falling asleep. |
| Mixed hyperlipidemia: LDL cholesterol 132 mg/dL, triglycerides 228, HDL 36 | active | confirmed | E78.2 | S — Synthetic cardiovascular risk factor. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | A1c and fasting glucose | At diagnosis; quarterly until at goal | Completed today | A1c 9.4 percent; fasting glucose 172 mg/dL |
| Laboratory | Classification: GAD65 antibodies and C-peptide | At diagnosis when type 1 or autoimmune diabetes is possible (young, lean or weight loss) | Completed today | GAD65 antibodies 1.2 IU/mL (negative); C-peptide 2.6 ng/mL (preserved); urine ketones negative last week |
| Laboratory | Urine albumin-to-creatinine ratio and eGFR | At diagnosis, then yearly; two of three abnormal over three to six months to confirm | Completed today | 46 mg/g, moderately increased; eGFR 106 last week |
| Laboratory | Lipid panel | At diagnosis | Completed today | LDL 132, triglycerides 228, HDL 36 |
| Laboratory | ALT with FIB-4 (fatty liver screen) and TSH | At diagnosis | Completed today | ALT 38; FIB-4 0.6 (low risk); TSH 1.8 |
| Laboratory | Vitamin B12 | Periodically on long-term metformin; baseline because he eats mostly vegetarian food | Completed today | 312 pg/mL, normal |
| Examination | Blood pressure, weight and BMI | Every visit | Completed today | 136/86; home 136/86; weight 72.8 kg, BMI 24.6 |
| Examination | Comprehensive foot examination | At diagnosis, then yearly | Completed today | Normal monofilament and vibration; pulses present |
| Referral | Dilated eye examination or retinal photographs | At diagnosis, then every one to two years | Ordered | Retinal photographs booked for the next visit |
| Self-management | Diabetes self-management education and medical nutrition therapy | At diagnosis | Referred | Dietitian this week: a mostly vegetarian plan built on his monastery meals |
| Self-management | Fasting risk assessment and plan | Before any religious fast | Completed today | Moderate risk; plan for fruit-and-milk fasts; no waterless fasts until glucose is steady |
| Medication safety | Hypoglycemia review | Every visit on insulin or a sulfonylurea | Not indicated | Neither used; sulfonylureas avoided because of his fasting |
| Self-management | Tobacco use | Every visit | Completed today | None now |
| Survey | Depression, anxiety and diabetes distress | At diagnosis and yearly | Up to date | PHQ-2 0 last week; full screens at the preventive visit |
| Self-management | Vaccinations | Yearly | Completed today | Influenza, COVID-19 and PCV20 today; hepatitis B and Tdap at the preventive visit |
Goal progress:
Immunizations given today: Influenza vaccine, this season; COVID-19 mRNA vaccine, this season's formula; Pneumococcal conjugate vaccine PCV20 [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026); Gujral UP, et al. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63 (PMID 23317344) (2013); Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991) (2021)
Follow-up: Preventive visit in three weeks. Diabetes review in five weeks, with retinal photographs and the repeat urine albumin. Call for vomiting, abdominal pain, drowsiness or glucose above 300 mg/dL. Next scheduled visit 1898-03-09: periodic preventive visit. [S]